At Merck KGaA, Darmstadt, Germany, we are committed to developing treatments that meet the needs of our diverse patients. To do so, we fully acknowledge the importance of adequately representing diverse participants in our clinical studies to ensure assessment of safety and efficacy of our drugs across different patient populations.

To learn more about our approach to achieve fair and equitable enrollment of diverse patients into our clinical studies, please make sure to click here to read our full Commitment on Diversity, Equity, and Inclusion in Clinical Study Participation.

While EMD Serono recognizes the value of a diverse pool of participants in clinical trials, we do not make any employment or contracting decisions based on race, ethnicity, gender, or any other legally protected characteristic or status. Nothing in EMD Serono’s communications regarding clinical trials should be understood otherwise.